KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $134.0 million.

  • Bio-Rad Laboratories' Net Cash Flow rose 9851.85% to $134.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $59.3 million, marking a year-over-year decrease of 2217.85%. This contributed to the annual value of $59.3 million for FY2025, which is 2217.85% down from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Net Cash Flow of $134.0 million as of Q4 2025, which was up 9851.85% from $25.4 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Net Cash Flow registered a high of $324.7 million during Q1 2022, and its lowest value of -$391.9 million during Q4 2021.
  • Over the past 5 years, Bio-Rad Laboratories' median Net Cash Flow value was $21.7 million (recorded in 2021), while the average stood at -$5.9 million.
  • Per our database at Business Quant, Bio-Rad Laboratories' Net Cash Flow surged by 993719.3% in 2021 and then tumbled by 47143.78% in 2022.
  • Bio-Rad Laboratories' Net Cash Flow (Quarter) stood at -$391.9 million in 2021, then surged by 83.27% to -$65.6 million in 2022, then increased by 27.72% to -$47.4 million in 2023, then surged by 242.45% to $67.5 million in 2024, then surged by 98.52% to $134.0 million in 2025.
  • Its Net Cash Flow stands at $134.0 million for Q4 2025, versus $25.4 million for Q3 2025 and -$135.2 million for Q2 2025.